1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    woman testing substance in laboratory dish, csl share price
    Healthcare Shares

    Could the CSL share price end 2024 above $300?

    | Zach Bristow

    Many believe the biotech giant can break $300 again

    Read more »

    A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.
    Healthcare Shares

    How much passive income would a $10,000 investment in CSL shares generate?

    | Tristan Harrison

    Can this stock offer healthy dividends?

    Read more »

    A head shot of legendary investor Warren Buffett speaking into a microphone at an event.
    How to invest

    How you could retire rich by investing like Warren Buffett with ASX shares

    | James Mickleboro

    The secret to retiring rich isn't so secret.

    Read more »

    Couple holding a piggy bank, symbolising superannuation.
    Retirement

    3 of the best ASX 200 shares to buy for your retirement portfolio

    | James Mickleboro

    Analysts think these blue chips could be worthy of a spot in a retirement portfolio.

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Can CSL shares deliver market-beating returns for investors?

    | James Mickleboro

    Is this a good place to invest your hard-earned money? Let's find out.

    Read more »

    a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
    Defensive Shares

    Don't get clever, just buy stability: 2 defensive ASX shares to buy now

    | James Mickleboro

    Analysts think these defensive shares would be top buys for investors right now.

    Read more »

    A man and a woman sit in front of a laptop looking fascinated and captivated.
    Best Shares

    4 ASX shares held by billionaire fund managers

    | Sebastian Bowen

    Is one of these four shares your next winner?

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Blue Chip Shares

    5 ASX 200 blue chip shares to buy now

    | James Mickleboro

    Analysts say these high-quality companies are top buys in May.

    Read more »

    A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
    Healthcare Shares

    Buy, hold or sell these 3 ASX 200 healthcare shares: Experts

    | Bronwyn Allen

    These experts reveal their calls on CSL, Resmed and Sonic Healthcare shares today.

    Read more »

    Investor sitting in front of multiple screens watching share prices
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    Two smiling work colleagues discuss an investment at their office.
    Blue Chip Shares

    These ASX 200 blue chip shares could rise 10% to 30%

    | James Mickleboro

    Analysts are tipping these blue chips to deliver big returns.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note